Deciphering the Role of Frizzled Receptors in Palatal Development
解读卷曲感受器在腭发育中的作用
基本信息
- 批准号:10646407
- 负责人:
- 金额:$ 10.93万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-08-01 至 2026-07-31
- 项目状态:未结题
- 来源:
- 关键词:AffectAllelesBiological AssayBirthBreedingBromodeoxyuridineCell Differentiation processCell LineageCellsCephalicChemotactic FactorsCleft LipCleft PalateCleft lip with or without cleft palateClustered Regularly Interspaced Short Palindromic RepeatsCodeCongenital AbnormalityCongenital DisordersControl AnimalCraniofacial AbnormalitiesDataDevelopmentDiseaseEmbryoEmbryonic DevelopmentEpithelial CellsFZD2 geneFailureFamilyFoundationsFutureGene TargetingGenesGeneticGenetic TranscriptionGoalsHealthcare SystemsHeterozygoteHistologyHomozygoteHumanIn Situ Nick-End LabelingIn VitroIncidenceInterventionLigandsLimb structureLinkLive BirthLoxP-flanked alleleMammalian OviductsMediatingMembraneMesenchymeMissense MutationModelingMolecularMorphologyMusMutationNeural Crest CellNewborn InfantNonsense MutationOpen Reading FramesPalatePathway interactionsPatientsPatternPhenotypePlayProcessPublishingRare DiseasesRegulationReporterResearchRobinow syndromeRoleSignal PathwaySignal TransductionSolidStructural Congenital AnomaliesSyndromeTestingTissuesTransgenesVariantWNT Signaling PathwayWNT5A geneautosomebeta catenincareer developmentcell fate specificationcell motilitycleft lip and palatecraniofacial developmentdirectional cellgenome editingimprovedmicroCTmigrationmouse modelmutantnew technologynovel therapeutic interventionnucleic acid deliveryorofacial cleftpalatal shelvespalatogenesisplanar cell polaritypreventprogramsreceptorresponsesingle-cell RNA sequencingtargeted treatment
项目摘要
PROJECT SUMMARY/ABSTRACT
Cleft lip and/or cleft palate has an incidence of approximately 1 in 700 births making it one of the most common
congenital birth defects. Gaining a more complete understanding of the genetics and signaling mechanisms
involved will provide a foundation for improving treatment of patients with orofacial clefts, ultimately reducing
an enormous burden on the healthcare system. Several signaling pathways intersect to regulate the proper
development of the palate which makes developing targeted therapies to treat or prevent cleft palate
challenging. Dissecting the components of each pathway involved will provide a more complete picture of
palatogenesis. The Wnt signaling pathway is an important regulator of palatal development and regulates early
patterning by cranial neural crest cells through regulation of induction, migration, and differentiation of these
cells. Wnt signaling also intersects many morphogenic pathways that regulate palatal shelf elongation,
elevation, and fusion. Frizzleds (FZDs) are transmembrane receptors for Wnt ligands and mutations in some of
the 10 FZD genes have been identified in patients with both syndromic and non-syndromic cleft lip and/or
palate. Specifically, heterozygous nonsense mutations in FZD2 have been identified in patient families with
Robinow Syndrome (RS) or Autosomal Dominant Omodysplasia (ADO), syndromes which are characterized
by limb reductions and craniofacial anomalies including cleft palate. While these mutations in FZD2 were
thought to cause haploinsufficiency, heterozygous deletion of Fzd2 in mice does not lead to cleft palate. We
will use mouse models harboring RS/ADO-associated mutations to better understand how FZD2 functions in
the developing palate. Given the association of mutations in other Wnt pathway genes (WNT5A, ROR2, DVL)
in RS and ADO, we hypothesize that these components signal together with FZD2 to regulate palatogenesis.
We hypothesize that FZD2 regulates cell migration and palatal patterning through a non-canonical WNT5A-
ROR2 pathway and further hypothesize that human RS- and ADO-associated Fzd2 mutations act dominantly
to interfere with Fzd signaling. To achieve these research goals, we propose the following aims: 1) determine
the phenotypic consequences of Fzd2 deletion and RS/ADO-Fzd2 mutations on palatal development in mice,
and 2) determine the molecular mechanisms behind Fzd2 regulation of palate development. Data generated in
this proposal will ultimately support the development of novel therapeutic approaches and interventions in Wnt
signaling-related diseases. These research plan and career development activities proposed here will form a
solid basis for my future independent research program.
项目概要/摘要
唇裂和/或腭裂的发病率约为七百分之一,使其成为最常见的疾病之一
先天性出生缺陷。更全面地了解遗传学和信号机制
所涉及的将为改善口面部裂患者的治疗奠定基础,最终减少
对医疗保健系统造成巨大负担。多个信号通路交叉以调节适当的
腭的发育使得开发靶向疗法来治疗或预防腭裂
具有挑战性的。剖析所涉及的每个途径的组成部分将提供更完整的图景
腭发生。 Wnt信号通路是腭发育的重要调节因子,调节早期发育
颅神经嵴细胞通过调节这些细胞的诱导、迁移和分化来形成模式
细胞。 Wnt 信号传导还与许多调节腭架伸长的形态发生途径相交叉,
提升、融合。卷曲蛋白 (FZD) 是 Wnt 配体的跨膜受体,并且某些配体发生突变
10 个 FZD 基因已在患有综合征性和非综合征性唇裂和/或
味觉。具体而言,已在患有以下疾病的患者家族中发现了 FZD2 杂合无义突变:
Robinow 综合征 (RS) 或常染色体显性遗传性发育不良 (ADO),其特征为
由肢体缩小和颅面异常(包括腭裂)引起。虽然 FZD2 的这些突变
小鼠中 Fzd2 的杂合缺失被认为会导致单倍体不足,但不会导致腭裂。我们
将使用含有 RS/ADO 相关突变的小鼠模型来更好地了解 FZD2 在
正在发育的味觉。考虑到其他 Wnt 通路基因(WNT5A、ROR2、DVL)突变的关联
在 RS 和 ADO 中,我们假设这些成分与 FZD2 一起发出信号来调节腭发育。
我们假设 FZD2 通过非规范的 WNT5A- 调节细胞迁移和腭模式。
ROR2 通路并进一步假设人类 RS 和 ADO 相关的 Fzd2 突变占主导地位
干扰 Fzd 信号。为了实现这些研究目标,我们提出以下目标:1)确定
Fzd2 缺失和 RS/ADO-Fzd2 突变对小鼠腭发育的表型影响,
2) 确定 Fzd2 调节上颚发育的分子机制。数据生成于
该提案最终将支持 Wnt 新型治疗方法和干预措施的开发
信号相关疾病。这里提出的这些研究计划和职业发展活动将形成一个
为我未来的独立研究计划奠定了坚实的基础。
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
β-catenin-dependent High Bone Mass Induced by Loss of APC in Osteoblasts Does Not Require Lrp5 or Lrp6.
- DOI:10.17912/micropub.biology.001000
- 发表时间:2023
- 期刊:
- 影响因子:0
- 作者:Diegel, Cassandra R;Michalski, Megan N;Williams, Bart O
- 通讯作者:Williams, Bart O
The Past, Present, and Future of Genetically Engineered Mouse Models for Skeletal Biology.
- DOI:10.3390/biom13091311
- 发表时间:2023-08-26
- 期刊:
- 影响因子:5.5
- 作者:Michalski, Megan N.;Williams, Bart O.
- 通讯作者:Williams, Bart O.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Megan Michalski其他文献
Megan Michalski的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Megan Michalski', 18)}}的其他基金
Deciphering the Role of Frizzled Receptors in Palatal Development
解读卷曲感受器在腭发育中的作用
- 批准号:
10284614 - 财政年份:2021
- 资助金额:
$ 10.93万 - 项目类别:
Deciphering the Role of Frizzled Receptors in Palatal Development
解读卷曲感受器在腭发育中的作用
- 批准号:
10454367 - 财政年份:2021
- 资助金额:
$ 10.93万 - 项目类别:
The Role of Macrophages in PTH Directed Osseous Wound Healing
巨噬细胞在 PTH 定向骨伤口愈合中的作用
- 批准号:
8907524 - 财政年份:2015
- 资助金额:
$ 10.93万 - 项目类别:
相似国自然基金
等位基因聚合网络模型的构建及其在叶片茸毛发育中的应用
- 批准号:32370714
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
基于人诱导多能干细胞技术研究突变等位基因特异性敲除治疗1型和2型长QT综合征
- 批准号:82300353
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
肠杆菌多粘菌素异质性耐药中phoPQ等位基因差异介导不同亚群共存的机制研究
- 批准号:82302575
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
ACR11A不同等位基因调控番茄低温胁迫的机理解析
- 批准号:32302535
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
玉米穗行数QTL克隆及优异等位基因型鉴定
- 批准号:
- 批准年份:2022
- 资助金额:55 万元
- 项目类别:面上项目
相似海外基金
The mechanism of CELF1 upregulation and its role in the pathogenesis of Myotonic Dystrophy Type 1
CELF1上调机制及其在强直性肌营养不良1型发病机制中的作用
- 批准号:
10752274 - 财政年份:2024
- 资助金额:
$ 10.93万 - 项目类别:
Role of intestinal serotonin transporter in post traumatic stress disorder
肠道血清素转运蛋白在创伤后应激障碍中的作用
- 批准号:
10590033 - 财政年份:2024
- 资助金额:
$ 10.93万 - 项目类别:
Modulation of NOD Strain Diabetes by ENU-Induced Mutations
ENU 诱导突变对 NOD 菌株糖尿病的调节
- 批准号:
10642549 - 财政年份:2023
- 资助金额:
$ 10.93万 - 项目类别:
Genetic and Functional Mechanisms in Citrate Transporter Disorder associated with SLC13A5
与 SLC13A5 相关的柠檬酸转运蛋白紊乱的遗传和功能机制
- 批准号:
10651203 - 财政年份:2023
- 资助金额:
$ 10.93万 - 项目类别:
Uncovering the Role of the MS4A Gene Family in Alzheimer's Disease
揭示 MS4A 基因家族在阿尔茨海默病中的作用
- 批准号:
10751885 - 财政年份:2023
- 资助金额:
$ 10.93万 - 项目类别: